Scribd
Upload
62 views23 pages

Business Analysis of Pharmaceutical Firms in Bangladesh

This document summarizes a study on the business analysis of pharmaceutical firms in Bangladesh. It outlines the history and growth of the pharmaceutical industry in Bangladesh since the 1980s. It also discusses key topics like the contribution to the economy, marketing, human resources, training, exporting, importing, foreign competition, research and development, and problems and prospects related to various aspects of the pharmaceutical industry in Bangladesh.

Uploaded by

broken reed
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
62 views23 pages

Business Analysis of Pharmaceutical Firms in Bangladesh

This document summarizes a study on the business analysis of pharmaceutical firms in Bangladesh. It outlines the history and growth of the pharmaceutical industry in Bangladesh since the 1980s. It also discusses key topics like the contribution to the economy, marketing, human resources, training, exporting, importing, foreign competition, research and development, and problems and prospects related to various aspects of the pharmaceutical industry in Bangladesh.

Uploaded by

broken reed
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
You are on page 1/ 23

BUSINESS ANALYSIS OF

PHARMACEUTICAL FIRMS IN
BANGLADESH: PROBLEM
AND PROSPECTS
PHARMACOECONOMICS & POLICY
BPH 3202
DEPARTMENT OF PHARMACY
PRIMEASIA UNIVERSITY
Presented by: Submitted to:
TITHI BHOWMIK (171-033-032) TAHMINA HAQUE
PALLAB MOZUMDER (171-034-032) LECTURER
FARGANA ISLAM (171-036-032) DEPARTMENT OF PHARMACY
ABDULLAH AL MAHMUD (171-037-032) PRIMEASIA UNIVERSITY
MUNIA AKTER (171-038-032)
INTRODUCTION
 There are several sectors in Bangladesh on which we can be proud of and
undoubtedly the pharmaceutical sector is one of these sectors.
 Some companies have already certified by different international regulatory
authorities like-UK-MHRA, Australia-TGA,EU etc for quality management
and quality products manufacturing.
 Drug manufacturing company-
 Allopathic Company no-263
 209 companies which are functional
 29 companies which are nonfunctional
 25 companies which are suspended in status
HISTORY
 In 2000,there were 210 licensed allopathic drug
manufacturing units in the country out of which 173 were in
active product.
 This pharma sector started to improve from 1980s.•
 National drug policy in 1982 and 2005 had major impact in
the development and growth of the pharmaceutical industry.
 After 1990s,some of the companies started producing insulin,
hormone and cancer combating drugs those were not
previously produced in the country.
ESTABLISHMENT YEAR OF VARIOUS
PHARMACEUTICAL COMPANY IN BANGLADESH
Sl No Name of the Companies Establishment year

1 Square Pharmaceutical Limited 1958

2 Incepta Pharmaceutical Limited 1999

3 Beximco Pharmaceutical Limited 1976

4 Eskayef Bangladesh Limited 1979

5 Opsonin pharmaceutical Limited 1956

6 Acme Laboratories Limited 1954

7 ACI Limited 1968


CONTRIBUTION OF DRUG INDUSTRY
IN ECONOMY IN BANGLADESH
 ACI in enriched with GMP certification from-
Kenya,Ivory Coast, Philippines.
 Our pharmaceuticals are exported to 30 countries of 4
continents.
 Square pharma started to export different antibiotics
and medicine across the world from 1987. Now it
exports it's medicine to 36 countries of the world.
 Eskayef pharma exported it's products to 21 countries
across of 4 continents.
METHOLOGY OF THE
STUDY

 Utilized both primary and secondary data


 Primary data collected from discussion with 110 concerned
executive of different pharmaceuticals companies, top level
officials of different pharmaceuticals company, officials of
directorate of drug administration, and interviewing the
customers of the drug.
 Secondary data collected from website, annual reports of different
pharmaceutical firm, important research paper, magazine,
relevant books newspaper, journals etc.
RESULT AND
DISCUSSION
Product-
There were 237 licenced allopathic drug manufacturer
 Among them 137 actively produce medicine
 Producing 5600 brand of medicine
 There are 1495 wholesale
 Around 37,700 retail drug

Anti -infective is the largest therapeutic class of locally produced


medicinal drug.
MARKETING
Marketing is a process by which company create value for
customer and build strong customer relationship in order to
capture value from customer in return.
Major criteria of marketing sector :
 Medical representative are key person in marketing
 For promotion, doctor & surgeon are targeted
 Special incentives are given to the doctor
 Major promotional strategies include printed promotional
material, physical sample & clinical materials.
HUMAN RESOURCES
Human resources are people-
 Recruited in the organization
 Targeted as the prime mover
 An important elements for success of any organization
 The sector consistently create job opportunities.
 Pharmaceutical companies contribute standard of health care &
standard of living.
Pharmaceutical industry believes that the human resources are most
valuable asset for organization
TRAINING AND
DEVELOPMENT
 Subsystem of organization
 Training is a skill enhancement process for non-managerial jobs
 Development is a skill enhancement process for managerial jobs

In development ,There has a broader scope and may not only be focused on present
job but also organizations
long term needs.
In Training,
 Learning programs
 Knowledge and skills
EXPORTING AND
BARRIER
Exporting
 Exports are a transferring process of goods from one country to
another.
 Medicine are promising sector
 Bangladesh are being export medicine into 151 countries,
including UK,USP .
 Netherlands and Denmark are the biggest importers
 Beximco Pharmaceuticals are leading exporters to the US,
received US FDA
Barrier
 Companies does not meet the agency’s requirements for
marketing USA .
 Bangladesh could not export the expected amount of
 pharmaceutical products due to some political issues
IMPORTING
 High dependency on imports for raw materials is major
challenge .
 Imports 99.5% mainly from China and India .
 In 2018 ,this sector is expected to grow at 15% year–on
–year to reach $ 5.11 billion by 2023 .
 API park
 Earn $ 23.8 billion global market
 Imported drugs are :Sevoflurane, Clarithromycine, anti –
cancer drugs etc
FOREIGN
COMPETITION
 Foreign competition made the country firms more eligible to face challenges
 At the beginning the foreign pharmaceuticals were dominating the marketing in our country .
 Among these competitors Roche ,Glaxo ,Smithkline ,Novartis .Novartis was playing most
dominant role.
 Now ,our industry is not afraid of this foreign competition
 And local industries does not face any rigorous problem in foreign country.
DAMPING
 Damping is a situation when in which a company sells its
products at lower price than the market price to capture the
market share.
 For example, Top Pharmaceutical company sold some Indian
medicine in the country market at a lower price than Bangladeshi
medicine but the medicine of developed countries & their origin
country are sold in a competitive price.
CUSTOMER CHOICE
 Customer is a person who buy the product as well as consumes the product.
 Choice depends on customer’s reliance upon company.
 Customer usually prefer some foreign medicine in case of sensetive problem.

Customer Choice of brand name:

Brand name Respondent (in


Square 38
Beximco 24
Incepta 16
Glaxo SmithKline 8
Acme 6
SK-F 4
Others 4
RESEARCH AND
DEVELOPMENT
Research is-
 Systematic & objective process of gathering recording & analyzing
data.
 Aid in making decisions and development

Multinational corporation are more concern about R&D than locally


owned company. R&D team are committed to the development and
introduction of novel drug and drug delivery system.
Competitive Position
 Pharmaceutical industry is facing competitive market domestically
 Square, Beximco, Incepta, Acme, SK-F are the competitor of one
another in medicine market.
PROBLEMS AND PROSPECTS OF
MARKETING
Problems of Marketing
 High turnover rate
 Cost of marketing affect the price of medicine
 Lack of professionalism, governmental law and this implementation
 Unstable political situation
 Smuggling

Prospects of Marketing •
 Proper marketing help a firm
 Free and fair competition
 To face the challenges of open market economy
PROBLEMS AND PROSPECT OF
FOREIGN COMPETITION
Problems
 More equipment, technology and plant facilities
 Can absorb loss
 Get government help

Prospect of Foreign Competition


 Made the county firms more eligible
 Pharmaceutical industries will become more efficient
 The local firm will not face any rigorous problem in foreign
country
PROBLEMS AND
PROSPECTS OF EXPORT
Problems
 Unstable political situation
 Problem of port
 Irresponsibility of customs officers
 Follow unfair promotional activities

Prospects
 Increasing the quality of medical products
 Surviving in future
 Monopolistic attitude of the firm is reduced
 Export brings foreign currency
PROBLEMS AND PROSPECTS
OF CUSTOMER CHOICES
Problems
 In producing rare drug
 Purchasing the medical products is not depending on the customer
choice
Prospects of Customer choices
 Increasing quality
 Producing rare drug at home
 Extensive promotional activity
PROBLEMS AND PROSPECTS
OF POWER DEVELOPMENT
Problems
 Do not getting power according to their demand
 Red-Tapism
 Lack of opportunity to supply the emergency power

Prospects
 Can entering the competitive market
 Pharmaceuticals may open a big door of prospect in
the foreign market

You might also like